These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 15870717)
1. The use of radiofrequency in cancer. Gillams AR Br J Cancer; 2005 May; 92(10):1825-9. PubMed ID: 15870717 [TBL] [Abstract][Full Text] [Related]
2. Hepatic radiofrequency under CT-fluoroscopy guidance. LaganĂ D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130 [TBL] [Abstract][Full Text] [Related]
3. Tumour ablation: current role in the liver, kidney, lung and bone. Gillams A Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S1-5. PubMed ID: 18852074 [TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes of percutaneous radiofrequency ablation versus adrenalectomy for adrenal metastases: a retrospective comparative study. Liu B; Mo C; Wang W; Ye J; Jiang C; Xie X; Huang J; Huang G; Long H; Xie X J Endocrinol Invest; 2020 Sep; 43(9):1249-1257. PubMed ID: 32166699 [TBL] [Abstract][Full Text] [Related]
5. Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs. Cassera MA; Potter KW; Ujiki MB; Swanström LL; Hansen PD Surg Endosc; 2011 Apr; 25(4):1088-95. PubMed ID: 20848143 [TBL] [Abstract][Full Text] [Related]
7. Comparison of General Anesthesia and Conscious Sedation During Computed Tomography-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma. Kim HJ; Park BK; Chung IS Can Assoc Radiol J; 2018 Feb; 69(1):24-29. PubMed ID: 29198818 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230 [TBL] [Abstract][Full Text] [Related]
9. Quality improvement guidelines for radiofrequency ablation of liver tumours. Crocetti L; de Baere T; Lencioni R Cardiovasc Intervent Radiol; 2010 Feb; 33(1):11-7. PubMed ID: 19924474 [TBL] [Abstract][Full Text] [Related]
10. Tumour ablation: current role in the kidney, lung and bone. Gillams A Cancer Imaging; 2009 Oct; 9 Spec No A(Special issue A):S68-70. PubMed ID: 19965298 [TBL] [Abstract][Full Text] [Related]
12. Radiofrequency Ablation of Lung Metastasis Not Suitable for Surgery: Experience in Siriraj Hospital. Tongdee T; Tantigate P; Tongdee R J Med Assoc Thai; 2015 Oct; 98(10):1019-27. PubMed ID: 26638594 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study. Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529 [TBL] [Abstract][Full Text] [Related]
14. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Jiao LR; Hansen PD; Havlik R; Mitry RR; Pignatelli M; Habib N Am J Surg; 1999 Apr; 177(4):303-6. PubMed ID: 10326848 [TBL] [Abstract][Full Text] [Related]